Table 1.

Demographics and Other Characteristics at Enrollment

	Level of Persistent Asthma Symptoms in Prior 4 Weeks
	Overall N=171	Mild N=81	Moderate N=51	Severe N=39
Age (years)*	6.4 (3.0)	6.8 (3.0)	5.7 (2.8)	6.5 (3.0)
Gender
Male	99 (58%)	48 (59%)	31 (61%)	20 (51%)
Female	72 (42%)	33 (41%)	20 (39%)	19 (49%)
Race
Black	59 (34%)	33 (41%)	13 (26%)	13 (33%)
White	37 (22%)	16 (20%)	12 (24%)	9 (23%)
Spanish/Puerto Rican/Hispanic/Latino/Mexi can/Chi cano/Cuban	50 (29%)	22 (27%)	15 (29%)	13 (33%)
Other	25 (15%)	10 (12%)	11 (22%)	4(10%)
Ethnicity
Hispanic	65 (38%)	29 (36%)	21 (41%)	15 (38%)
Non-Hispanic	106 (62%)	52 (64%)	30 (59%)	24 (62%)
Insurance type
Medicaid	109 (64%)	49 (60%)	31 (61%)	29 (74%)
Private Insurance	62 (63%)	32 (40%)	20 (39%)	10 (26%)
Language spoken at home
English	120 (70%)	59 (73%)	33 (65%)	28 (72%)
Spanish	5 (3%)	1 (1%)	1 (2%)	3 (8%)
English and Spanish	44 (26%)	21 (26%)	15 (29%)	8 (20%)
Other	2 (1%)	0	2 (4%)	0
Caregiver age (years)*	33.4 (7.9)	34.3 (7.7)	32.2 (7.3)	33.2 (1.4)
Caregiver education
High School Graduate or greater	124 (72%)	59 (73%)	38 (74%)	27 (69%)
Less than High School	47 (28%)	22 (27%)	13 (26%)	12 (31%)
Caregiver marital status
Married	64 (37%)	36 (44%)	19 (37%)	9 (23%)
Single	107 (63%)	45 (56%)	32 (63%)	30 (77%)
Caregiver smokes	54 (32%)	24 (30%)	16 (31%)	14 (36%)
One or more smoker in home	83 (48%)	41 (51%)	21 (41%)	21 (54%)
Reason for visit **
Asthma (attack or follow-up)	36 (21%)	10 (12%)	12 (24%)	14 (36%)
Other (well child, non-asthma sick or follow-up)	135 (79%)	71 (88%)	39 (76%)	25 (64%)
Current controller medication prescription reported***	96 (56%)	39 (48%)	32 (63%)	25 (64%)

^*Mean (SD)

^**statistically significant based on p-value <.05

^***Controller medication defined as inhaled corticosteroid, mast cell stabilizer or leukotriene modifier